Clinical Trials

Carcinoma, Non-Small-Cell Lung

NCT04459078 2022-12-02

Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma

63 enrolled

Adenocarcinoma of Lung

NCT04749394 2022-08-16

A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy

42 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT04901754 2021-12-08

CAMERA

38 enrolled

Small Cell Lung Carcinoma

NCT05001412 2021-08-12

Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC

36 enrolled

Extensive Stage Small Cell Lung Cancer

NCT04968002 2021-07-20

Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy

Phase 2/3 Unknown

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04950400 2021-07-06

A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT04490421 2021-02-08

Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer.

45 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04390984 2021-01-11

Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients

22 enrolled

NSCLC

NCT04683198 2020-12-24

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

69 enrolled

Small Cell Lung Carcinoma

NCT04659785 2020-12-09

A Study of Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC）

Phase 1/2 Unknown

53 enrolled

Small Cell Lung Carcinoma

NCT04506242 2020-09-09

Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer

74 enrolled

NSCLC

NCT03267654 2020-08-03

Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03389087 2020-07-10

Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer

Small Cell Lung Carcinoma

NCT04453930 2020-07-01

A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy（Irinotecan Plus Platinum）and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer（SCLC）

Small Cell Lung Carcinoma

NCT04425135 2020-06-11

Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC

59 enrolled

Lung Neoplasms

NCT04203485 2020-05-08

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

762 enrolled

PD-L1 Positive Non-small Cell Lung Cancer

NCT04133337 2019-10-21

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT04128800 2019-10-16

Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer

Small Cell Lung Carcinoma

NCT03709953 2018-10-24

Spark-AL003

33 enrolled

Lung Neoplasms

NCT03651219 2018-08-29

Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer

90 enrolled

Small Cell Lung Carcinoma

NCT03416231 2018-01-31

Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)

NSCLC

NCT03411967 2018-01-26

Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC

Lung Neoplasms

NCT03389256 2018-01-03

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

144 enrolled

Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT03376191 2017-12-18

Apatinib in Advanced Non-squamous，NSCLC

Unknown

100 enrolled

Lung Neoplasms

NCT03135977 2017-12-07

Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy

36 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT03201146 2017-11-17

Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Phase 1/2 Unknown

48 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02995187 2017-09-07

Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)

25 enrolled

Small Cell Lung Carcinoma

NCT02515435 2017-08-18

The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02332512 2017-02-24

ANSWER

417 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03050411 2017-02-10

Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02980809 2016-12-02

Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer

Small Cell Lung Carcinoma

NCT02780778 2016-05-23

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02733107 2016-04-12

The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer

25 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02704767 2016-03-10

Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma

Lung Neoplasms

NCT02691871 2016-02-25

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR

Adenocarcinoma of Lung

NCT02540824 2015-09-04

Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01287962 2013-12-09

Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer

480 enrolled